Casandra
Casandra Test Code LC41400Version 1 (DRAFT)
Performing Lab
Lab LabcorpLab Test ID 252482
Severe Combined Immunodeficiency (SCID): CD3D (Full Gene Sequencing)
Also known as: c-erb-2, Colorectal carcinoma, CRC, HER-2/neu, HER2
Clinical Use
Order TestUse
HER2 is a known negative predictive biomarker in colorectal cancer (CRC). Recent trials have established HER2 as a therapeutic target in CRC. This assay assists in determining eligibility for HER2 therapy in patients with CRC.
Special Instructions
Not provided.
Limitations
Use of fixatives other than 10% formalin may not yield reliable results.
Test Details
Methodology
Immunohistochemistry (IHC)
Biomarkers
Targets not provided.
LOINC Codes
Order Codes
- 41103-3 - Gene XXX Mut Anl Bld/T
Result Codes
- 41103-3 - Gene XXX Mut Anl Bld/T
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Unknown
Volume
Not provided
Minimum Volume
Not provided
Causes for Rejection
Tumor type other than colorectal cancer (CRC); fixative other than neutral buffered formalin; insufficient tumor cellularity
Similar Tests
Other tests from different labs that may be relevant
Severe Combined Immunodeficiency (SCID) Gene Panel, Varies
Mayo Clinic Lab
CD3, technical only
MPLN
Invitae Comprehensive Severe Combined Immunodeficiency (SCID) and Combined Immunodeficiency (CID) Panel
Invitae Corporation
Cellular and Humoral Immunodeficiency Panel
Prevention Genetics
Lymphocyte Subset Panel 7 - Congenital Immunodeficiencies
ARUP Laboratories